At the news
? NEUTRALIMPACT 4/10 425 filed Apr 17, 2026 at 16:06 ET
Penumbra Inc sent a letter to its stockholders urging them to vote in favor of the proposed acquisition by Boston Scientific Corporation, with the special meeting scheduled for May 6, 2026. The board unanimously recommends approval.
- Penumbra's board unanimously recommends stockholders vote FOR the merger with Boston Scientific.
- Special meeting to vote on the merger is scheduled for May 6, 2026.
- Failing to vote has the same effect as voting against the merger.
- The proxy statement/prospectus was declared effective on April 1, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access